Recent advances in the management of acute promyelocytic leukemia /
Abdelhamid Mohamed Fouad
Recent advances in the management of acute promyelocytic leukemia / التطورات الحديثة فى علاج اللوكيمية البرومييلوسيتية الحادة Abdelhamid Mohamed Fouad ; Supervised Thoria Mohamed Abdelhamid , Mohamed Abdelmooti Mohamed , Raafat Mohamed Abdelfattah - Cairo : Abdelhamid Mohamed Fouad , 2010 - 133 P. : charts , facsimiles ; 30cm
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medicine
Acute promyelocytic leukemia (APL) was first identified as a distinct subtype of acute myeloid leukemia in 1957 by leif hillestad . It is called M3 in the French - American - British classification with a variant type referred to as microgranular (M3v in the French - American - British nomenclature ) APL acounts for 10% - 15% of all cases of acute myeloid leukemia with several thousand new cases diagnosed worldwide each year
Acute myeloid leukemia Acute promyelocytic leukemia Arsenic trioxide
Recent advances in the management of acute promyelocytic leukemia / التطورات الحديثة فى علاج اللوكيمية البرومييلوسيتية الحادة Abdelhamid Mohamed Fouad ; Supervised Thoria Mohamed Abdelhamid , Mohamed Abdelmooti Mohamed , Raafat Mohamed Abdelfattah - Cairo : Abdelhamid Mohamed Fouad , 2010 - 133 P. : charts , facsimiles ; 30cm
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medicine
Acute promyelocytic leukemia (APL) was first identified as a distinct subtype of acute myeloid leukemia in 1957 by leif hillestad . It is called M3 in the French - American - British classification with a variant type referred to as microgranular (M3v in the French - American - British nomenclature ) APL acounts for 10% - 15% of all cases of acute myeloid leukemia with several thousand new cases diagnosed worldwide each year
Acute myeloid leukemia Acute promyelocytic leukemia Arsenic trioxide